Stay updated on Fazirsiran Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fazirsiran Safety & Efficacy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:41:07.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding the study details for Fazirsiran Injection in patients with Alpha-1 Antitrypsin Deficiency, including the study's purpose, participant criteria, and specific procedural information. The revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    8%
    Check dated 2025-04-16T01:08:43.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed the date 2025-03-25 while adding the dates 2025-01-14 and 2024-12-30.
    Difference
    0.6%
    Check dated 2025-04-08T19:34:54.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect new dates and a version revision, indicating a shift in the timeline and software versioning.
    Difference
    0.5%
    Check dated 2025-04-01T13:38:23.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T13:40:33.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T08:55:11.000Z thumbnail image

Stay in the know with updates to Fazirsiran Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.